News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
July, 2025
July 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Ruben Mesa: Excited to be a co-investigator of the MANIFEST2 trial presented by Alessandro Vannucchi at EHA25
Wake Forest University School of Medicine/LinkedIn
Jun 14, 2025, 06:53

Ruben Mesa: Excited to be a co-investigator of the MANIFEST2 trial presented by Alessandro Vannucchi at EHA25

Ruben Mesa, President and Executive Director of Atrium Health Levine Cancer Institute and Atrium Health Wake Forest Baptist Comprehensive Cancer Center, shared a post on LinkedIn:

“Excited to be a co-investigator of the MANIFEST2 trial presented by Alessandro Vannucchi at EHA25. The 72-week data of the combination of Pelabresib plus Ruxolitinib showed durably superior responses for the combination for control of splenomegaly and dual responders.”

Ruben Mesa: Excited to be a co-investigator of the MANIFEST2 trial presented by Alessandro Vannucchi at EHA25

More posts featuring Ruben Mesa.

Alessandro Vannucchi cancer EHA25 MANIFEST2 trial OncoDaily Oncology Pelabresib Ruben Mesa ruxolitinib
Special Coverage
Blog
Jul 3, 2025, 16:46
Priscilla Chan: Accelerating Imaging Science so Researchers Can See Biology More Clearly
Insight
Jul 3, 2025, 16:42
Highlights From ESMO Gastrointestinal Cancers Congress 2025 by Arndt Vogel
Career
Jul 3, 2025, 16:19
David Weinstock Has Been Appointed Head of the Oncology Disease Translational Area in pRED at Roche
Career
Jul 3, 2025, 16:10
Bruno Vialli Has Been Appointed LATAM Procurement Manager for Media, Comms and Events at Sanofi
Insight
Jul 3, 2025, 16:01
Paolo Tarantino: First Positive Phase 3 Trial for a Bispecific ADC
Insight
Jul 3, 2025, 15:48
ASMIRT shares updates on advocacy, research, and student support in Australia - ESTRO
Oncolibrary
Jul 3, 2025, 15:17
FORTITUDE-101 Study Updates 2025: Bemarituzumab Plus mFOLFOX6 in FGFR2b-Positive Gastric and GEJ Cancer
Blog
Jul 3, 2025, 13:19
The SAGITTARIUS Consortium's 1st Meeting - Sagittarius EU Project
Blog
Jul 3, 2025, 13:09
Boris Pasche: Karmanos Cancer Institute is Privileged to Have Reggie Doxtader's Expertise
Blog
Jul 3, 2025, 12:59
Mora Guardamagna: An Incredible and Truly Enriching Experience at the MCCR workshop
Blog
Jul 3, 2025, 12:37
The Monograph on Talc - IARC
Oncolibrary
Jul 3, 2025, 12:18
Glioblastoma Cure Rate: What Patients Should Know